Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Salini Mohanty"'
Autor:
Salini Mohanty, Jui-Hua Tsai, Ning Ning, Ana Martinez, Rishi P. Verma, Marieke Heisen, Jessica Weaver, Kristen A. Feemster, Bianca Chun, Thomas W. Weiss, Jordana K Schmier
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTAs higher-valent pneumococcal conjugate vaccines (PCVs) become available for pediatric populations in the US, it is important to understand healthcare provider (HCP) preferences for and acceptability of PCVs. US HCPs (pediatricians, family me
Externí odkaz:
https://doaj.org/article/00e26ba049014e4383bf9cb8bf3d7a56
Publikováno v:
International Journal of Infectious Diseases, Vol 143, Iss , Pp 107023- (2024)
ABSTRACT: Objectives: To evaluate the clinical and economic outcomes in adults hospitalized with invasive pneumococcal disease (IPD) and noninvasive all-cause pneumonia (ACP) overall and by antimicrobial resistance (AMR) status. Methods: Hospitalized
Externí odkaz:
https://doaj.org/article/ff12dbc583b44d919254d0af9d183803
Autor:
Tianyan Hu, Yan Song, Nicolae Done, Salini Mohanty, Qing Liu, Eric M. Sarpong, Esteban Lemus-Wirtz, James Signorovitch, Thomas Weiss
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background Streptococcus pneumoniae remains a leading cause of morbidity, mortality, and healthcare resource utilization (HRU) among children. This study quantified HRU and cost of acute otitis media (AOM), pneumonia, and invasive pneumococc
Externí odkaz:
https://doaj.org/article/5183ed6638a24bda9b75ab049fd2fdd6
Autor:
Tianyan Hu, Eric M. Sarpong, Yan Song, Nicolae Done, Qing Liu, Esteban Lemus-Wirtz, James Signorovitch, Salini Mohanty, Thomas Weiss
Publikováno v:
Pneumonia, Vol 15, Iss 1, Pp 1-15 (2023)
Abstract Background Pneumonia is the most serious form of acute respiratory infection and Streptococcus pneumoniae is a leading cause of pediatric bacterial pneumonia. Pneumococcal conjugate vaccines were introduced in the United States (US) in 2000
Externí odkaz:
https://doaj.org/article/23c8e558c53241389668108740fe0d6e
Autor:
Salini Mohanty, Bélène Podmore, Ana Cuñado Moral, Thomas Weiss, Ian Matthews, Eric Sarpong, Ignacio Méndez, Nawab Qizilbash
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in 2006 and the 13-valent pneumococcal conjugate vaccine (PCV13) in 2010 in the UK. PCVs are active immunization for the prevention of invasive disease, pneumonia a
Externí odkaz:
https://doaj.org/article/a501e19a36a445c7a1eadd47c92f3fcf
Autor:
Salini Mohanty, Bélène Podmore, Ana Cuñado Moral, Ian Matthews, Eric Sarpong, Alessandra Lacetera, Nawab Qizilbash
Publikováno v:
Pneumonia, Vol 15, Iss 1, Pp 1-11 (2023)
Abstract Background Pneumococcal disease is a leading cause of communicable disease morbidity and mortality globally. We aimed to estimate invasive pneumococcal disease (IPD), pneumococcal pneumonia (PP) and all-cause pneumonia (ACP) incidence rates
Externí odkaz:
https://doaj.org/article/9368808d72ff440db580671598523dda
Autor:
Tianyan Hu, Yan Song, Nicolae Done, Qing Liu, Eric M. Sarpong, Esteban Lemus-Wirtz, James Signorovitch, Salini Mohanty, Thomas Weiss
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Invasive pneumococcal disease (IPD) is a major cause of pediatric morbidity and mortality. Pneumococcal conjugate vaccines (PCVs) were introduced in the US in 2000 (PCV7) and 2010 (PCV13). This study estimated the annual incidence
Externí odkaz:
https://doaj.org/article/0b28c58853e04ce88fa86994a4a5bec8
Autor:
Salini Mohanty, Bélène Podmore, Ana Cuñado Moral, Ian Matthews, Eric Sarpong, Agueda Azpeitia, Nawab Qizilbash
Publikováno v:
PLoS ONE, Vol 18, Iss 4, p e0283084 (2023)
ObjectiveTo estimate healthcare resource utilisation (HCRU) and costs associated with pneumococcal disease (PD) in children aged ≤17 years in England from 2003-2019.MethodsA retrospective study in children aged ≤17 years was conducted using the C
Externí odkaz:
https://doaj.org/article/e6ebd6ca41b5450c821386b4541464d4
Autor:
Tianyan Hu, Nicolae Done, Tanaz Petigara, Salini Mohanty, Yan Song, Qing Liu, Esteban Lemus-Wirtz, James Signorovitch, Eric Sarpong, Thomas Weiss
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Acute otitis media (AOM) is a leading cause of office visits and antibiotic prescriptions in children. Pneumococcal conjugate vaccines were introduced in the USA in 2000 (7-valent, PCV7) and 2010 (13-valent, PCV13). Expanded valen
Externí odkaz:
https://doaj.org/article/62c85861c51c4611ae6da1517403fa30
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
Use of pneumococcal conjugate vaccines (PCVs) has greatly reduced the incidence of invasive pneumococcal disease (IPD). V114 (VAXNEUVANCE™, Merck Sharp & Dohme Corp. a subsidiary of Merck & Co. Inc. Kenilworth, NJ, USA) is a 15-valent PCV currently
Externí odkaz:
https://doaj.org/article/bfa4354495184d969be4ccd27f6821af